Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorTaumedika s.r.l.
Study to validate the safety and efficacy of the Hyaluronic Acid +Collagen filler 40 patients will undergo through 3 visits one to asses the health and apply the filler one after 4 weeks to check the results one after 16 weeks for the final check and results validation Safety assessed with analysis of the Adverse Events
all sexes
caucasic
18 to 70 years
non smoker
Pregnancy
milking
smoker
alcohol or drugs abuse
Taumedika s.r.l.
Lead sponsor
Nextrasearch S.r.l.s.
Collaborator